eprchd: Estrogen plus Progestin and the Risk of Coronary Heart Disease (eprchd)
Description
This data was reconstructed from the curves in figure 2
(Manson 2003).Compares placebo to hormone treatment.
Usage
eprchd
Arguments
Format
A dataframe with 16608 observations and 3 variables:
time
Years (continuous)
status
0=censored, 1=event
treatment
placebo,
estPro
References
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf,
A. R., Lasser, N. L., ... & Strickland, O. L. (2003). Estrogen plus
progestin and the risk of coronary heart disease. New England Journal of
Medicine, 349(6), 523-534.